Exit readiness for medical groups and primary care means building profitability reporting by provider and location, managing payer mix actively, documenting provider productivity against targets, and proving that margin holds under institutional scrutiny. We build the financial infrastructure over 12 to 24 months so the group survives due diligence without last-minute margin erosion.
No cost. 15 minutes. No obligation.
Exit readiness for medical groups and primary care means building profitability reporting by provider and location, managing payer mix actively, documenting provider productivity against targets, and proving that margin holds under institutional scrutiny. We build the financial infrastructure over 12 to 24 months so the group survives due diligence without last-minute margin erosion.
Primary care groups add providers to drive growth, but profitability per provider often remains invisible until a buyer requests detailed reporting during diligence. Blended EBITDA hides low-performing providers, payer mix drifts toward Medicaid without active management, and overhead allocation fails to reflect true location or provider economics. Buyers applying 3 to 5x EBITDA multiples to primary care groups demand proof that margin is durable, that adverse payer mix is not accelerating, and that provider productivity is documented and transferable. Without provider-level profitability, managed payer mix trending, and denial rate tracking by location, the group either fails diligence or accepts a discounted multiple.
Profitability reporting by provider and location, separating direct provider compensation, allocated overhead, and payer mix to isolate margin contributors and detractors
Payer mix trending by location with Medicaid, Medicare, and commercial percentages tracked monthly, showing stability or managed improvement over 18 to 24 months
Provider productivity documentation against wRVU or visit volume targets, with variance reporting and corrective action history that proves management capability
Denial rate tracking by provider, location, and top three payers, with appeals workflow and recovery metrics that demonstrate operational rigor
Scheduling utilization reporting showing appointment slots filled, cancellation rates, and provider capacity utilization to validate revenue runway
Quality of earnings preparation specific to primary care, normalizing non-recurring expenses, validating revenue recognition by payer, and reconciling working capital to cash collections
Primary care groups typically transact at 3 to 5x EBITDA, with broader medical practices spanning 6 to 12x depending on specialty mix and commercial payer concentration. Buyers discount groups with adverse Medicaid drift, unmanaged denial rates, or invisible provider-level profitability. Strategic buyers and private equity both require proof that margin holds when examined by provider, that payer mix is stable or improving, and that referral relationships transfer beyond founding physicians. Groups that cannot report profitability by provider or demonstrate managed payer mix face multiple compression or withdrawn offers during diligence.
See the healthcare multiples benchmark for where medical groups and primary care transact today.
Buyers do not pay a multiple on the EBITDA you report. They pay it on the EBITDA they accept after add-backs.
Where healthcare practices transact today, by vertical, on normalized EBITDA.
| Vertical | EBITDA multiple | Basis | Source |
|---|---|---|---|
| Medical Groups / Primary Care | 3 to 12x | EBITDA; primary care 3 to 5x, broader medical 6 to 12x | Sofer Advisors |
exit readiness and m&a for medical groups and primary care is the intersection page. Read the full medical groups and primary care advisory angle, the general exit readiness and m&a overview, or run the Value Creation Assessment to see where your practice stands.
We recommend 18 to 24 months before a targeted transaction. Primary care exit readiness requires building profitability reporting by provider, stabilizing or improving payer mix trends, and documenting provider productivity against benchmarks. Buyers applying 3 to 5x EBITDA multiples demand at least 12 months of clean trailing financials with visible provider-level margin, managed payer mix, and denial rate control. Starting 90 days before marketing leaves no time to correct adverse payer drift, remove unprofitable providers, or build the reporting infrastructure that survives institutional diligence.
Buyers will either walk or discount the purchase price to reflect hidden risk. Without provider-level profitability, the group cannot prove which providers drive margin, which locations are dilutive, or whether new hires will replicate historical EBITDA. Strategic buyers and private equity both model future capacity and margin by provider; if the group presents only blended EBITDA, the buyer assumes adverse selection and applies a lower multiple or requires post-close earnouts tied to margin verification. Groups that build provider profitability reporting before marketing reduce buyer uncertainty and support the higher end of the 3 to 5x range.
We build monthly payer mix trending by location over 18 to 24 months, showing Medicaid, Medicare, and commercial percentages with variance analysis. Buyers focus on commercial payer stability because it drives margin durability; if Medicaid is growing faster than commercial without management intervention, the buyer assumes continued adverse drift and discounts the multiple. We document payer contracting history, credentialing timelines, and any active initiatives to shift mix toward higher-margin commercial plans. This reporting proves the group manages payer mix intentionally rather than accepting passive drift, which protects the valuation during diligence.
Buyers expect profitability reporting by provider and location, payer mix trending with at least 12 months of history, denial rate tracking by payer, and provider productivity documented against wRVU or visit volume targets. The group must reconcile cash collections to revenue recognition by payer class, isolate non-recurring expenses, and demonstrate working capital stability. If these systems are absent, buyers either decline to issue an LOI or include extensive post-LOI diligence contingencies that delay closing and increase re-trade risk. We build these reporting systems in the 18 months before marketing so the group enters diligence with institutional-grade financials that support the stated EBITDA and justify the 3 to 5x multiple.
We build 13-week rolling cash forecasts that isolate provider-level collections, payer lag by mix, and denial drag so…
See the medical groups and primary care anglePrimary care groups default to pass-through tax structures that penalize high-earning providers, ignore Section 199A…
See the medical groups and primary care angleFor medical groups, owner compensation structure determines whether distributions pass tax efficiently to partners…
See the medical groups and primary care angleWe align your draw strategy, reinvestment priorities, and retained earnings to a unified personal wealth plan, ensuring…
See the medical groups and primary care angleMedical groups and primary care practices allocate capital without visibility into provider-level profitability or…
See the medical groups and primary care angleWe build provider-level and payer mix profitability systems so primary care groups know which providers and contracts…
See the medical groups and primary care anglePrimary care and medical groups that lack provider-level profitability reporting, payer mix tracking, and clean denial…
See the medical groups and primary care anglePrimary care groups add providers faster than they add profit, and without CFO-level oversight, unprofitable providers…
See the medical groups and primary care angleProduction per provider, collection rate, and payer mix. Dental practice value lives in the hygiene schedule a
See advisory angleRepeat revenue, provider productivity, and margin per service line. Med spas are valued on whether the model r
See advisory angleRevenue per doctor, capture rate, and the transition to corporate consolidation buyers.
See advisory angleThe Keystone Value Creation Assessment™ audits your last 12 to 36 months and gives you a written summary whether you engage us or not. If there is not a clear opportunity to create value, we will tell you directly.